Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
ACTIVE_NOT_RECRUITING
NA
3065 participants
INTERVENTIONAL
2014-10-31
2027-12-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Comparison of Digital Breast Tomosynthesis to Conventional Mammography
NCT03442478
Breast Cancer Detection: Comparison of Breast Tomosynthesis and Conventional Mammography
NCT01669148
Tomosynthesis in Screening Mammography
NCT01086241
Test of Digital Breast Tomosynthesis vs. Regular Mammography in Detecting Breast Cancer in Women Undergoing Diagnostic Mammography
NCT00535327
Prospective Trial of Digital Breast Tomosynthesis (DBT) in Breast Cancer Screening.
NCT03733106
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
SCREENING
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Tomosynthesis + FFDM
Women enrolled to DBT Arm will undergo manufacturer-defined DBT
Tomosynthesis
Three-dimensional imaging of both breasts in standard CC and MLO views
FFDM - Standard of Care for Screening
Women enrolled to the FFDM Arm will undergo bilateral digital mammogram with standard CC and MLO views acquired
No interventions assigned to this group
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Tomosynthesis
Three-dimensional imaging of both breasts in standard CC and MLO views
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Scheduled for screening mammogram
* Able to tolerate digital breast tomosynthesis and full-field digital mammographic imaging required by protocol
* Willing and able to provide a written informed consent.
Exclusion Criteria
* Have new breast complaints (e.g. lump, nipple discharge)
* Have had a mammogram of both breasts within the last 11 months
* Previous personal history of breast cancer
* Has breast enhancements (e.g. implants or injections)
* Pregnancy or intent to become pregnant.
40 Years
FEMALE
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Eastern Cooperative Oncology Group
NETWORK
Sunnybrook Health Sciences Centre
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Dr. Roberta Jong
Principal Investigator
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Roberta A Jong, MD
Role: PRINCIPAL_INVESTIGATOR
Sunnybrook Health Sciences Centre
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
X-Ray 505 (Under the BCCA Screening Mammography Program of BC)
Vancouver, British Columbia, Canada
Breast Health Centre at BC Women's Hospital + Health Centre
Vancouver, British Columbia, Canada
The Ottawa Hospital
Ottawa, Ontario, Canada
Sunnybrook Health Sciences Centre
Toronto, Ontario, Canada
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
410000662
Identifier Type: OTHER_GRANT
Identifier Source: secondary_id
001-2014b
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.